Treating Blood Cancers
The Leukemia & Lymphoma Society
Categorias: Ciencia y medicina
Añadir a Mi Lista
Escuchar el último episodio:
Michael Tees, MD, MPH, Colorado Blood Cancer Institute, Denver, CO
Recorded on March 12, 2024
Michael Tees, MD, MPH
Director, Lymphoma Program
Lymphoma Executive Committee Member, Sarah Cannon Research Institute
Associate Member, Colorado Blood Cancer Institute
Denver, CO
Join Dr. Michael Tees from the Colorado Blood Cancer Institute, as he discusses
Chimeric antigen receptor (CAR) T-cell therapy in 2024. Dr. Tees provides an overview of immunotherapy and approved indications, how to discuss treatment options with your patients, what to consider when referring patients for CAR T-cell therapy, how to prepare patients, and educating patients and caregivers about toxicity management. He also provides insight into the limitations of CAR-T therapy, as well as future directions. Tune in to this informative episode today to learn more!
This episode is supported by Bristol Myers Squibb, Johnson & Johnson|Legend Biotech, Kite, a Gilead Company, and Novartis Pharmaceuticals Corporation.
Episodios anteriores
-
125 - CAR T-cell Therapy in 2024 Fri, 12 Apr 2024 - 0h
-
124 - Supporting Healthcare Professionals to Reduce Burnout Thu, 14 Mar 2024 - 0h
-
123 - Creating a Roadmap for Adult Survivorship Care Tue, 30 Jan 2024 - 0h
-
122 - Highlights from attending the 2023 ASH Annual Meeting Wed, 10 Jan 2024 - 0h
-
121 - A Conversation on Transplantation Wed, 20 Dec 2023 - 0h
-
120 - Addressing Barriers & Disparities for Hispanic/Latinx Blood Cancer Survivors Throughout the Care Journey Wed, 13 Dec 2023 - 0h
-
119 - Survivorship Care of Older Adults: Addressing the Unique Needs Tue, 21 Nov 2023 - 0h
-
118 - Measuring Quality of Life in Adolescent and Young Adult Cancer Care Wed, 01 Nov 2023 - 0h
-
117 - Supporting Adolescent and Young Adult (AYA) Survivors Thu, 31 Aug 2023 - 0h
-
116 - Understanding and Treating LGBTQI+ Patients with Cancer Fri, 02 Jun 2023 - 0h
-
115 - Chronic Myeloid Leukemia: What HCPs Need to Know Tue, 21 Feb 2023 - 0h
-
114 - 2022 ASH Annual Meeting: Highlights from the Perspective of a Conference Attendee Fri, 20 Jan 2023 - 0h
-
113 - Understanding Waldenström Macroglobulinemia Wed, 04 Jan 2023 - 0h
-
112 - CAR T-cell Therapy in Review 2022: Updates in Treatment Wed, 21 Dec 2022 - 0h
-
111 - Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia: Part II Wed, 16 Nov 2022 - 0h
-
110 - AML: Insights, Updates, and Takeaways Thu, 27 Oct 2022 - 0h
-
109 - Insights from Attending the 2022 Society of Hematologic Oncology (SOHO) Annual Meeting Fri, 14 Oct 2022 - 0h
-
108 - What’s New in the Treatment of BPDCN? Tue, 20 Sep 2022 - 0h
-
107 - Mastocytosis: Insight into a Rare Blood Cancer Thu, 11 Aug 2022 - 0h
-
106 - The Role of Genomics in Treating Blood Cancers Wed, 20 Jul 2022 - 0h
-
105 - Insights into Pediatric Survivorship for the HCP Thu, 23 Jun 2022 - 0h
-
104 - PedAL: First-of-Its-Kind Global Master Clinical Trial for Pediatric Acute Leukemia Thu, 09 Jun 2022 - 0h
-
103 - The Role of the Primary Care Physician in Treating Chronic Blood Cancers: Focus on Myeloma Tue, 24 May 2022 - 0h
-
102 - CAR T-cell Therapy in 2022: What You Need to Know Part II Tue, 26 Apr 2022 - 0h
-
101 - Everything You Need to Know About Cutaneous T-cell Lymphoma Thu, 14 Apr 2022 - 0h
-
100 - A Deep Dive into Myelofibrosis Wed, 23 Mar 2022 - 0h
-
99 - Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia: Part I Thu, 17 Feb 2022 - 0h
-
98 - The COVID-19 Vaccine and Your Patient with Cancer Wed, 10 Mar 2021 - 0h
-
97 - Managing Treatment for Patients with Relapsed/Refractory Lymphoma Wed, 24 Feb 2021 - 0h
-
96 - What’s New in Treatment for Acute Myeloid Leukemia (AML) Wed, 03 Feb 2021 - 0h
-
95 - Progress in the Treatment of Follicular Lymphoma Wed, 20 Jan 2021 - 0h
-
94 - Current Applications of Cancer Genomics: Focus on CLL Tue, 15 Dec 2020 - 0h
-
93 - Supporting LGBTQI Cancer Patients Tue, 17 Nov 2020 - 0h
-
92 - A Deeper Dive into MRD: A Conversation with Gail Roboz, MD Mon, 19 Oct 2020 - 0h
-
91 - Communicating with Caregivers: Strategies for HCPs Tue, 22 Sep 2020 - 0h
-
90 - Communicating with the Young Adult with Blood Cancer Thu, 03 Sep 2020 - 0h
-
89 - Facilitating the Learning Experience of Children and AYAs During and After Cancer Treatment Mon, 10 Aug 2020 - 0h
-
88 - Myelodysplastic Syndromes (MDS): Caring for Low and High-Risk Patients Wed, 22 Jul 2020 - 0h
-
87 - Treating Children with Cancer during the COVID-19 Pandemic Wed, 17 Jun 2020 - 0h
-
86 - CML: Treatment Considerations and Survivorship Challenges Tue, 02 Jun 2020 - 0h
-
85 - Understanding the Complexities of Myeloproliferative Neoplasms Thu, 21 May 2020 - 0h
-
84 - COVID-19: What Healthcare Professionals Need to Know Mon, 20 Apr 2020 - 0h
-
83 - The Role of the PA and Nurse in Treating Patients during the COVID-19 Pandemic Tue, 14 Apr 2020 - 0h
-
82 - Insights in to Transplantation with Dr. Fredrick Appelbaum Tue, 14 Apr 2020 - 0h
-
81 - Disparities in Cancer Care: Focus on Myeloma Tue, 24 Mar 2020 - 0h
-
80 - Long-Term and Late Effects of Childhood Cancer: A Conversation on Survivorship Tue, 25 Feb 2020 - 0h
-
79 - Compassion Fatigue in Cancer Care Thu, 23 Jan 2020 - 0h
-
78 - Mantle Cell Lymphoma: Disease and Treatment Updates Tue, 17 Dec 2019 - 0h
-
77 - Treatment Considerations for NHL as a Chronic Disease Tue, 19 Nov 2019 - 0h
-
76 - CAR T-cell Therapy: The Nurse’s Role in Treating Patients Tue, 22 Oct 2019 - 0h
Mostrar más episodios
5